WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013158961) COMBINATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG WITH AN ANTI-HISTAMINIC DRUG INTENDED FOR OPHTHALMIC USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/158961    International Application No.:    PCT/US2013/037314
Publication Date: 24.10.2013 International Filing Date: 19.04.2013
IPC:
A61K 9/00 (2006.01), A61K 31/407 (2006.01), A61K 31/55 (2006.01), A61K 45/06 (2006.01)
Applicants: ALLERGAN, INC. [US/US]; 2525 Dupont Drive Irvine, California 92612 (US).
RAJAN, Kothanda Raman Thyaga [IN/IN]; (IN)
Inventors: RAJAN, Kothanda Raman Thyaga; (IN)
Agent: ENE, Doina; Allergan, Inc. 2525 Dupont Drive Irvine, California 92612 (US)
Priority Data:
61/635,506 19.04.2012 US
Title (EN) COMBINATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG WITH AN ANTI-HISTAMINIC DRUG INTENDED FOR OPHTHALMIC USE
(FR) COMBINAISON D'UN MÉDICAMENT ANTI-INFLAMMATOIRE NON STÉROÏDIEN AVEC UN MÉDICAMENT ANTIHISTAMINIQUE DESTINÉE À UNE UTILISATION OPHTALMIQUE
Abstract: front page image
(EN)The present invention is directed to a stable formulation of a combination of ketorolac (non-steroidal anti-inflammatory drug) with olopatadine (anti-histaminic drug) intended for ophthalmic use. This pharmaceutical composition is used for treatment of ophthalmic diseases and conditions, particularly seasonal ocular surface allergy.
(FR)La présente invention concerne une formulation stable d'une combinaison de kétorolac (médicament anti-inflammatoire non stéroïdien) avec de l'olopatadine (médicament antihistaminique), destinée à une utilisation ophtalmique. Cette composition pharmaceutique est utilisée pour le traitement de maladies et d'états ophtalmiques, en particulier une allergie de surface oculaire saisonnière.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)